Tag: Patent

Shaping the Future of Life Sciences IP at LSPN Europe 2026

Basel will once again become a hub for innovation and intellectual property on 22-23 September, and MLL Legal is proud to be part of the conversation as a partner of the LSPN (Life Sciences Patent Network) Europe 2026 Conference.

Firm News

MLL Legal represented Bayer Intellectual Property GmbH in a successful appeal before the Swiss Federal Supreme Court

The patent litigation team of MLL Legal successfully represented Bayer Intellectual Property GmbH in an appeal before the Swiss Federal Supreme Court against decision by the Swiss Federal Patent Court rejecting a request for preliminary injunction against Helvepharm AG’s rivaroxaban generic.

Publication

Patent Litigation 2022 Switzerland – Trends and Developments

Chambers and Partners, Global Practice Guides, Patent Litigation 2022, 15 February 2022

Firm News

MLL successfully represented AstraZeneca in patent infringement proceedings against Sandoz before the Swiss Federal Patent Court

MLL represented the patent proprietor AstraZeneca in patent infringement proceedings against Sandoz, concerning AstraZeneca’s fulvestrant formulation patent. The Federal Patent Court decided that AstraZeneca’s patent was valid and infringed by Sandoz’s generic product.

Firm News

MLL successfully defends Lipomed’s deferiprone business

MLL successfully represented Lipomed AG and Lipomed GmbH in patent opposition proceedings before the Board of Appeal of the European Patent Office and coordinated the international patent litigation concerning Lipomed's deferiprone business.

Firm News

MLL successfully represented HOYA Surgical Optics GmbH in patent annulment proceedings against Alcon AG before the Swiss Federal Patent Court

Meyerlustenberger Lachenal AG acted as Swiss counsel to Hoya Surgical Gmbh against Alcon AG, both well known for the development and marketing of intraocular lenses. The MLL team was led by Michael Ritscher.

Firm News

Europeen Patent Forum 2014, 11. September 2014, Paris, France

Simon Holzer and Michael Ritscher are speaking abut the Swiss Focus at 11.55 h